Vanderbilt Health One Hundred Oaks — Nashville, Tennessee

Vanderbilt Health One Hundred Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Vanderbilt Health One Hundred Oaks has participated in 9 clinical trials with 6 currently active.

Therapeutic areas: Diabetes Mellitus, Type 2, Triple-Negative Breast Cancer, SARS-CoV-2 Infection.

Sponsors: Eli Lilly and Company, Merck Sharp & Dohme LLC, Shionogi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Health One Hundred Oaks?

Vanderbilt Health One Hundred Oaks has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Health One Hundred Oaks conducted?

Vanderbilt Health One Hundred Oaks has 9 clinical trials on record, with 6 currently active. Their work covers Diabetes Mellitus, Type 2, Triple-Negative Breast Cancer, SARS-CoV-2 Infection.

Is Vanderbilt Health One Hundred Oaks accredited by Crixeo Clinical Trials?

Vanderbilt Health One Hundred Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Health One Hundred Oaks?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.